부산대학교 도서관

R, Kramer; T K, Weber; R, Arceci; N, Ramchurren; W V, Kastrinakis; G, Steele; I C, Summerhayes

British Journal of Cancer. 71:670-675

Glass, David R.; Mayer-Blackwell, Koshlan; Ramchurren, Nirasha; Parks, K. Rachael; Duran, George E.; Wright, Anna K.; Bastidas Torres, Armando N.; Islas, Laura; Kim, Youn H.; Fling, Steven P.; Khodadoust, Michael S.; Newell, Evan W.

Cell Rep Med

Whiteaker JR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Zhao L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Schoenherr RM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Huang D; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Lundeen RA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Voytovich U; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Kennedy JJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Ivey RG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Lin C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Murillo OD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Lorentzen TD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Colantonio S; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Caceres TW; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Roberts RR; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Knotts JG; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Reading JJ; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Perry CD; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Richardson CW; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Garcia-Buntley SS; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Bocik W; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.; Hewitt SM; Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, United States.; Chowdhury S; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Vandermeer J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Division of Medical Oncology, Department of Internal Medicine, University of Washington, Seattle, WA, United States.; Smith SD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Division of Medical Oncology, Department of Internal Medicine, University of Washington, Seattle, WA, United States.; Gopal AK; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Division of Medical Oncology, Department of Internal Medicine, University of Washington, Seattle, WA, United States.; Ramchurren N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Fling SP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Wang P; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Paulovich AG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

N, Ramchurren; K, Cooper; I C, Summerhayes

International Journal of Cancer. 62:237-244

Odunsi K; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Qian F; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Lugade AA; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Yu H; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Geller MA; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN, USA.; Fling SP; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Kaiser JC; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Lacroix AM; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; D'Amico L; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Ramchurren N; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Morishima C; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Disis ML; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Dennis L; NanoString Technologies Inc., Seattle, WA, USA.; Danaher P; NanoString Technologies Inc., Seattle, WA, USA.; Warren S; NanoString Technologies Inc., Seattle, WA, USA.; Nguyen VA; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.; Ravi S; Department of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY, USA.; Tsuji T; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Rosario S; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Zha W; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Hutson A; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Liu S; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Lele S; Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Zsiros E; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; McGray AJR; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Chiello J; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Koya R; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Chodon T; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Morrison CD; Department of Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Putluri V; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.; Putluri N; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.; Mager DE; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.; Enhanced Pharmacodynamics LLC, Buffalo, NY, USA.; Gunawan R; Department of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY, USA.; Cheever MA; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Battaglia S; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Matsuzaki J; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

D M, Raidoo; N, Ramchurren; Y, Naidoo; S, Naidoo; W, Müller-Esterl; K D, Bhoola

Immunopharmacology. 33:104-107

Su T; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Duran GE; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Kwang AC; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Ramchurren N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Fling SP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Kim YH; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.; Khodadoust MS; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

N, Ramchurren; R, Karmali

Prostaglandins, Leukotrienes and Essential Fatty Acids. 53:95-101

J M, Fitzgerald; N, Ramchurren; K, Rieger; P, Levesque; M, Silverman; J A, Libertino; I C, Summerhayes

JNCI Journal of the National Cancer Institute. 87:129-133

Ryu H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Bi TM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Pulliam TH; Department of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA.; Sarkar K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Church CD; Department of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA.; Kumar N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Lab Medicine and Pathology, University of Washington, Seattle, WA, USA.; Mayer-Blackwell K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Jani S; Department of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA; Department of Lab Medicine and Pathology, University of Washington, Seattle, WA, USA.; Ramchurren N; Cancer Immunotherapy Trails Network, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hansen UK; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Hadrup SR; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Fling SP; Cancer Immunotherapy Trails Network, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Koelle DM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Lab Medicine and Pathology, University of Washington, Seattle, WA, USA; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA; Benaroya Research Institute, Seattle, WA, USA.; Nghiem P; Department of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA.; Newell EW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Lab Medicine and Pathology, University of Washington, Seattle, WA, USA. Electronic address: enewell@fredhutch.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

P, Levesque; N, Ramchurren; K, Saini; A, Joyce; J, Libertino; I C, Summerhayes

International Journal of Cancer. 55:785-790

Phillips D; Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Matusiak M; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Gutierrez BR; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Bhate SS; Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Bioengineering, Stanford University Schools of Engineering and Medicine, Stanford, CA, 94305, USA.; Barlow GL; Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Jiang S; Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.; Demeter J; Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Smythe KS; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Pierce RH; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Fling SP; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Ramchurren N; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Cheever MA; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Goltsev Y; Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; West RB; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Khodadoust MS; Division of Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Kim YH; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Division of Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Schürch CM; Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA. christian.schuerch@med.uni-tuebingen.de.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA. christian.schuerch@med.uni-tuebingen.de.; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany. christian.schuerch@med.uni-tuebingen.de.; Nolan GP; Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA. gnolan@stanford.edu.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA. gnolan@stanford.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Hansen, U.K.; Frej, M.S.; Bentzen, A.K.; Tvingsholm, S.A.; Hadrup, S.R.; Simões, A.M.C.; Church, C.D.; Nghiem, P.T.; Becker, J.C.; Fling, S.P.; Ramchurren, N.; Topalian, S.L.

In: Journal of Clinical Investigation. (Journal of Clinical Investigation, 15 April 2024, 134(8))

Pachynski RK; Department of Medicine, Washington University School of Medicine, St Louis, MO, USA rkpachynski@wustl.edu lawrence.fong@ucsf.edu.; Morishima C; University of Washington, Seattle, Washington, USA.; Szmulewitz R; University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.; Harshman L; Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Current affiliation: Surface Oncology, Cambridge, MA, USA.; Appleman L; UPMC, Pittsburgh, Pennsylvania, USA.; Monk P; Ohio State University James Cancer Hospital, Columbus, Ohio, USA.; Bitting RL; Wake Forest Baptist Health, Winston-Salem, North Carolina, USA.; Kucuk O; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.; Millard F; University of California San Diego, La Jolla, California, USA.; Seigne JD; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.; Fling SP; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Maecker HT; Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, USA.; Duault C; Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, USA.; Ramchurren N; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Hess B; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; D'Amico L; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Lacroix A; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Kaiser JC; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Morre M; RevImmune, Paris, France.; Grégoire A; RevImmune, Paris, France.; Cheever M; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Yu EY; University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Fong L; University of California San Francisco, San Francisco, California, USA rkpachynski@wustl.edu lawrence.fong@ucsf.edu.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

KRAMER, R; WEBER, TK; ARCECI, R; RAMCHURREN, N; KASTRINAKIS, WV; STEELE, G; SUMMERHAYES, IC

BRITISH JOURNAL OF CANCER; APR 1995, 71 4, p670-p675, 6p.

N.J. Miller; C. Church; S. Fling; R. Kulikauskas; N. Ramchurren; M. Shinohara; M. Cheever; S.L. Topalian; P. Nghiem

Journal of Investigative Dermatology. 137:S45

W V, Kastrinakis; N, Ramchurren; K M, Rieger; D T, Hess; M, Loda; G, Steele; I C, Summerhayes

Oncogene. 11(4)

Greene E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Biostatistics Bioinformatics and Epidemiology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Finak G; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Biostatistics Bioinformatics and Epidemiology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; D'Amico LA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Bhardwaj N; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA.; Church CD; Division of Dermatology, Department of Medicine University of Washington, Seattle, WA, USA.; Morishima C; Division of Dermatology, Department of Medicine University of Washington, Seattle, WA, USA.; Ramchurren N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Taube JM; Bloomberg Kimmel Institute for Cancer Immunotherapy and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Nghiem PT; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Dermatology, Department of Medicine University of Washington, Seattle, WA, USA.; Cheever MA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Fling SP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Gottardo R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Biostatistics Bioinformatics and Epidemiology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101767765 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3899 (Electronic) Linking ISSN: 26663899 NLM ISO Abbreviation: Patterns (N Y) Subsets: PubMed not MEDLINE

J H, Botha; K M, Robinson; N, Ramchurren; R J, Norman

Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA). 35:119-123

Bhardwaj N; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. nina.bhardwaj@mssm.edu.; Friedlander PA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Pavlick AC; NYU Perlmutter Cancer Center, New York, NY, USA.; Ernstoff MS; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Gastman BR; Cleveland Clinic, Cleveland, OH, USA.; Hanks BA; Duke University Medical Center, Durham, NC, USA.; Curti BD; Providence Portland Medical Center, Portland, OR, USA.; Albertini MR; University of Wisconsin, Madison, WI, USA.; Luke JJ; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.; Blazquez AB; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Balan S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Bedognetti D; Sidra Medicine, Doha, Qatar.; Beechem JM; NanoString Technologies, Seattle, WA, USA.; Crocker AS; Celldex Therapeutics, Hampton, NJ, USA.; D'Amico L; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Danaher P; NanoString Technologies, Seattle, WA, USA.; Davis TA; Genocea Biosciences, Cambridge, MA, USA.; Hawthorne T; Celldex Therapeutics, Hampton, NJ, USA.; Hess BW; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Keler T; Celldex Therapeutics, Hampton, NJ, USA.; Lundgren L; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Morishima C; University of Washington, Seattle, WA, USA.; Ramchurren N; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Rinchai D; Sidra Medicine, Doha, Qatar.; Salazar AM; Oncovir, Inc., Washington, DC, USA.; Salim BA; Axio Research, Seattle, WA, USA.; Sharon E; National Institutes of Health, Bethesda, MD, USA.; Vitale LA; Celldex Therapeutics, Hampton, NJ, USA.; Wang E; Sidra Medicine, Doha, Qatar.; Warren S; NanoString Technologies, Seattle, WA, USA.; Yellin MJ; Celldex Therapeutics, Hampton, NJ, USA.; Disis ML; University of Washington, Seattle, WA, USA.; Cheever MA; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Fling SP; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. sfling@fredhutch.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE